Use of the Dye Stain Assay and Ultraviolet Light Test for Assessing Vaginal Insertion of Placebo-Filled Applicators Before and After Sex
暂无分享,去创建一个
T. Cornelison | B. Friedland | M. Einstein | B. Herold | M. Keller | Juan Lin | Lauren Katzen | Niall Buckley | Jennifer Walsh | Sarah Littlefield | X. Xue
[1] A. Minnis,et al. Methodological Lessons from Clinical Trials and the Future of Microbicide Research , 2013, Current HIV/AIDS Reports.
[2] B. Friedland,et al. An Evaluation of Methods to Improve the Reporting of Adherence in a Placebo Gel Trial in Andhra Pradesh, India , 2013, AIDS and Behavior.
[3] M. Einstein,et al. Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel: Candidate Antimicrobial Contraceptive , 2012, PloS one.
[4] Joelle M. Brown,et al. Trypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulations. , 2012, Sexually transmitted diseases.
[5] C. Mauck,et al. Dyeing to know: the use of vaginal applicator staining and other techniques to assess adherence to product use in microbicide trials. , 2012, Sexually transmitted diseases.
[6] R. Cone,et al. Evaluation of Microbicide Gel Adherence Monitoring Methods , 2012, Sexually transmitted diseases.
[7] Kevin W P Miller,et al. Developmental Validation of RSID™‐Semen: A Lateral Flow Immunochromatographic Strip Test for the Forensic Detection of Human Semen * , 2012, Journal of forensic sciences.
[8] B. Mensch,et al. Validation of a Dye Stain Assay for Vaginally Inserted Hydroxyethylcellulose-Filled Microbicide Applicators , 2011, Sexually transmitted diseases.
[9] C. Hendrix,et al. A Randomized Trial to Assess Anti-HIV Activity in Female Genital Tract Secretions and Soluble Mucosal Immunity Following Application of 1% Tenofovir Gel , 2011, PloS one.
[10] P. Hewett,et al. Assessing the Reporting of Adherence and Sexual Activity in a Simulated Microbicide Trial in South Africa: An Interview Mode Experiment Using a Placebo Gel , 2011, AIDS and Behavior.
[11] Lynn Morris,et al. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women , 2010, Science.
[12] S. Hillier,et al. Limitations of the Dye-Based Method for Determining Vaginal Applicator Use in Microbicide Trials , 2009, Sexually transmitted diseases.
[13] C. Mauck. Biomarkers of semen exposure. , 2009, Sexually transmitted diseases.
[14] B. Friedland,et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.
[15] B. Herold,et al. Assessment of Adherence to Product Dosing in a Pilot Microbicide Study , 2007, Sexually transmitted diseases.
[16] D. Phillips,et al. Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials. , 2007, Contraception.
[17] G. Doncel,et al. In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. , 2005, AIDS research and human retroviruses.
[18] J. Yuenger,et al. ON HEALTH AND BEHAVIOR MEASUREMENT Program in Health and Behavior Measurement , 2004 .
[19] D. Phillips,et al. Assay for Establishing Whether Microbicide Applicators Have Been Exposed to the Vagina , 2004, Sexually transmitted diseases.
[20] J. Malm,et al. Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues. , 2002, Molecular human reproduction.